IMAX stock soars to 52-week high, reaching $26.85

IMAX (NYSE:IMAX) Corporation’s stock has soared to a 52-week high, hitting a price level of $26.85, marking a significant milestone for the $1.39 billion entertainment technology company. According to InvestingPro data, analysts see further upside potential with price targets reaching as high as $33. This peak reflects a robust year-over-year growth, with the stock experiencing an impressive 85.74% increase in value over the past year. The surge to this new high underscores investor confidence and a strong market performance for IMAX, as the company continues to expand its global footprint and enhance its cutting-edge cinematic technologies. The company maintains a healthy financial position with a current ratio of 3.31, indicating strong liquidity. Discover 12 more key insights about IMAX with an InvestingPro subscription, including detailed valuation analysis and growth prospects.

In other recent news, IMAX Corporation has been the subject of several significant developments. The company maintained its Buy rating and $30.00 price target from Benchmark analysts following a record-breaking performance during the Chinese New Year box office in China, where IMAX achieved an all-time high for first-day revenue, totaling $12 million. This milestone was particularly notable as IMAX captured nearly 5% of the total market share while only representing 1% of total screens.

In a strategic move, IMAX has also announced an exclusive partnership with Netflix, Inc. (NASDAQ:NFLX) to premiere the highly anticipated film "Narnia," directed by Oscar-nominated Greta Gerwig. The film is set to have a two-week exclusive run in IMAX theaters worldwide, starting Thanksgiving 2026.

Analysts from Rosenblatt Securities reaffirmed a positive stance on IMAX, maintaining a Buy rating and a price target of $28.00, citing a strong lineup of films slated for 2025 as a reason for future success. Meanwhile, Benchmark analysts also maintained their Buy rating and $30.00 price target for IMAX, projecting that IMAX China’s box office growth will be fueled by a compelling mix of high-budget local language films and Hollywood blockbusters.

Lastly, Benchmark upgraded its outlook on IMAX, increasing the price target to $30.00 from the previous $22.00, while maintaining a Buy rating for the stock. IMAX has been included in the ’Best Ideas for 2025’ list, highlighting the firm’s optimism about the company’s future performance. These recent developments underline the positive outlook for IMAX’s financial prospects and its strategic position in the entertainment industry.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.